Roy Debajyoti, Ghosh Maitrayee, Rangra Naresh Kumar
Faculty of Pharmacy, CV Raman Global University, Bhubaneswar, Odisha, India.
Chitkara College of Pharmacy, Chitkara University, Punjab, India.
Phytother Res. 2024 Dec 17. doi: 10.1002/ptr.8410.
Diabetes mellitus is a chronic metabolic disorder marked by hyperglycemia, resistance to insulin, and impaired function of the pancreatic β-cells; it advances into more serious complications like nephropathy, neuropathy, cardiovascular disease, and retinopathy; herbal medicine has indicated promise in not just mitigating the symptoms but also in managing the complications. This review would aim to evaluate the pharmacological aspect of the botanical therapies Anacardium occidentale, Allium sativum, Urtica dioica, and Cinnamomum zeylanicum, as well as their bioactive phytochemicals, quercetin, resveratrol, berberine, and epigallocatechin gallate (EGCG). In this review, we discuss their mechanisms for secreting the insulin sensitizers, carbohydrate-hydrolyzing enzymes, reduction in oxidative stress and effectiveness against diabetic complications-all through sensitivity to insulin. Great emphasis is laid on the integration of multi-omics technologies such as genomics, proteomics, metabolomics, and transcriptomics in the discovery of bioactive compounds. The nature of the technologies can evaluate the intrinsic complexities of herbal pharmacology and even identify therapeutic candidates. Finally, the review refers to the meagre clinical trials on the efficiency of these compounds in the metabolism of humans. High-quality future research, such as human large-scale trials, would be emphasized; improvement in the clinical validity of a drug might come from improved study design, better selection of potentially usable biomarkers, and enhanced safety profiles to guarantee efficacy with lessened risks.
糖尿病是一种慢性代谢紊乱疾病,其特征为高血糖、胰岛素抵抗和胰腺β细胞功能受损;它会发展成更严重的并发症,如肾病、神经病变、心血管疾病和视网膜病变;草药不仅在减轻症状方面显示出前景,而且在管理并发症方面也有效果。本综述旨在评估植物疗法(如腰果、大蒜、荨麻和锡兰肉桂)及其生物活性植物化学物质(槲皮素、白藜芦醇、黄连素和表没食子儿茶素没食子酸酯(EGCG))的药理学方面。在本综述中,我们讨论它们分泌胰岛素增敏剂、碳水化合物水解酶、降低氧化应激以及对抗糖尿病并发症的机制——所有这些都是通过对胰岛素的敏感性实现的。我们非常强调整合多组学技术,如基因组学、蛋白质组学、代谢组学和转录组学,以发现生物活性化合物。这些技术的性质可以评估草药药理学的内在复杂性,甚至识别治疗候选物。最后,综述提到了关于这些化合物在人体代谢中效率的临床试验较少。将强调高质量的未来研究,如人类大规模试验;药物临床有效性的提高可能来自改进的研究设计、更好地选择潜在可用的生物标志物以及增强安全性概况,以确保疗效并降低风险。